DFO
AMGN icon

Duquesne Family Office’s Amgen AMGN Stock Holding History

Duquesne Family Office’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-158,900
Closed -$22.3M – 36
2014
Q3 		$22.3M Buy
+158,900
New +$20.7M 2.74% 11
2014
Q1 		– Sell
-231,000
Closed -$26.4M – 22
2013
Q4 		$26.4M Hold
231,000
– – 1.76% 22
2013
Q3 		$25.9M Buy
+231,000
New +$25M 3.06% 12

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Duquesne Family Office's AMGN Position: Q4 2014 in Review

Duquesne Family Office sold out of Amgen (AMGN) in Q4 2014, closing a stake of 158,900 shares — an estimated $22.3M sold.

Duquesne Family Office first reported a position in AMGN in Q3 2013 and held it in 3 quarters. The position peaked at $26.4M in Q4 2013. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • Duquesne Family Office reported no remaining Amgen position as of Q4 2014 after selling out during the quarter.
  • Duquesne Family Office sold 158,900 Amgen shares in Q4 2014, an estimated $22.3M.
  • Duquesne Family Office first reported a position in Amgen in Q3 2013 and held it in 3 quarters.
  • Duquesne Family Office's Amgen position peaked at $26.4M in Q4 2013.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Duquesne Family Office's 13F filing for Q4 2014, filed 12 Feb 2015.